Gordon Findlay, an executive from Novo Nordisk, collapsed in the Oval Office on Thursday afternoon while President Trump was unveiling a new plan to lower the cost of popular weight-loss drugs, including Ozempic.
According to witnesses, Findlay quickly received medical assistance and was helped back to his feet. He is expected to make a full recovery.
“Gordon Findlay of Novo Nordisk collapsed in the Oval Office Thursday afternoon as President Trump announced a plan to reduce the price of weight-loss drugs, including Ozempic.”
The incident occurred during a televised announcement highlighting federal efforts to make vital health treatments more affordable. The moment was captured by cameras present in the room.
Footage of the event has circulated widely online, with many expressing concern for Findlay’s health and discussing the broader implications of the President's plan for the pharmaceutical sector.
Report by web editor Jodi Leese Glusco. Published and updated on November 6, 2025.
Author’s summary: A Novo Nordisk executive briefly collapsed at the Oval Office during President Trump’s announcement on lowering drug prices, but recovered after receiving prompt medical aid.